Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) posted quarterly Other Non-Current Assets of $988922.1 for Q4 2025, down 62.01% year-on-year from $2.6 million in Q4 2024, and down 58.27% on a QoQ basis from $2.4 million in Q2 2025.

Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025) Analysis & Trends

Zhengye Biotechnology Holding (ZYBT) has reported Other Non-Current Assets for 3 consecutive years, with $988922.1 the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Assets fell 62.01% year-over-year to $988922.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $988922.1 (down 62.01% YoY) and the FY2025 annual result came in at $1.0 million, down 60.85% from the prior year.
  • Other Non-Current Assets eased to $988922.1 in Q4 2025 per ZYBT's latest filing, from $2.4 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ZYBT reached as high as $2.6 million in Q4 2024 and fell as low as $903323.6 in Q4 2023.
  • A 3-year average of $1.7 million and a median of $1.7 million in 2025 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 188.16% — and 2025, when it plunged 62.01%.
  • Year by year, Other Non-Current Assets stood at $903323.6 in 2023, then surged by 188.16% to $2.6 million in 2024, then sank by 62.01% to $988922.1 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $988922.1, $2.4 million, and $2.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Zhengye Biotechnology Holding 85.23 Mn 85.93 Mn - 988,922.10

Historic Data

Download Data
DateValue
Dec 31, 2025 988,922.10
Jun 30, 2025 2.37 Mn
Dec 31, 2024 2.60 Mn
Dec 31, 2023 903,323.61